AI INVESTORS COMPLETE THREE-YEAR CYCLE FROM DOUBT TO ECSTASY TO REGRETAI'S EXPENSIVE PROBLEM: IT COSTS TOO MUCH TO DO TOO LITTLEAPOTEX PRICES IPO AT TOP, BETS MARKET LOVES GENERICSSEQUOIA'S DUAL-PRICE EQUITY: ONE VALUATION, TWO TRUTHSTRUMP DISCOVERS SOCIALISM, CALLS IT A 'BEAUTIFUL PARTNERSHIP'AI INDUSTRY BLAMES BEIJING FOR NOTICING ITS POWER BILLSBENCHMARK DISCOVERS GROWTH FUNDS, ONLY 20 YEARS LATEGOOGLE DRAFTS WATER GUIDELINES WHILE COMMUNITIES DROWN ITS PERMITSAI INVESTORS COMPLETE THREE-YEAR CYCLE FROM DOUBT TO ECSTASY TO REGRETAI'S EXPENSIVE PROBLEM: IT COSTS TOO MUCH TO DO TOO LITTLEAPOTEX PRICES IPO AT TOP, BETS MARKET LOVES GENERICSSEQUOIA'S DUAL-PRICE EQUITY: ONE VALUATION, TWO TRUTHSTRUMP DISCOVERS SOCIALISM, CALLS IT A 'BEAUTIFUL PARTNERSHIP'AI INDUSTRY BLAMES BEIJING FOR NOTICING ITS POWER BILLSBENCHMARK DISCOVERS GROWTH FUNDS, ONLY 20 YEARS LATEGOOGLE DRAFTS WATER GUIDELINES WHILE COMMUNITIES DROWN ITS PERMITS
Est. when term sheets
outnumbered good ideas
www.dumbcapital.com
North American VC & M&A News — Unfiltered, Unimpressed, Unprofitable
North America Edition
Tuesday, June 9, 2026
Free (Like Your Equity)
★ Billion Dollar Club

AI Investors Complete Three-Year Cycle From Doubt to Ecstasy to Regret

The venture capital industry has now experienced an entire emotional arc without anyone proving AI actually makes money.

The venture capital industry has completed what can only be described as a three-year emotional odyssey through artificial intelligence investment, cycling from rational skepticism to euphoric delusion and back again—all without establishing whether any of it actually works. Historic sums of capital poured into AI companies before a single investor could point to a reliable example of the technology automating meaningful work at scale. The suspicion phase, wherein rational actors questioned whether they were funding an emperor with no clothes, gave way almost immediately to mania, driven by the emergence of Claude and autonomous agents that made early believers feel vindicated. We are now entering phase three: the reckoning, wherein the market appears to be waking up to a rather uncomfortable realization that capital allocation and technological feasibility may not be the same thing.

What makes this cycle so exquisite is its sheer predictability masquerading as novelty. Investors poured historic sums into AI ventures based on the premise that the technology could "reliably automate work"—a phrase that functioned as both promise and prayer, carrying no actual evidence of commercial viability. The arrival of Claude and autonomous agents provided just enough plausible demonstration to transform suspicion into certainty in the minds of people whose business model requires certainty. But here's the satirical meat: the same investors who once worried about pouring money into unproven technology are now discovering that demonstration of technological capability and demonstration of profitable scaling are apparently different things entirely. Somewhere between "it works in the lab" and "it makes us money" lies a canyon that venture capital had hoped to simply ignore.

The three-phase arc itself deserves examination, because it suggests a pattern that has haunted tech investing for decades. Suspicion (rational caution) gives way to mania (irrational exuberance) gives way to reckoning (oh no). This is not unique to AI. It is the default operating system of venture capitalism—a cycle that has played out in cloud computing, mobile, blockchain, and countless other domains where real technology gets married to unrealistic timelines and valuations. The difference with AI is the sheer velocity: three years to complete a cycle that previously took a decade suggests either that the technology moved faster or that investors' patience for due diligence has simply evaporated. History suggests it's the latter.

The emergence of Claude Code and autonomous agents was seized upon as vindication because it arrived at precisely the moment investors needed vindication most. These tools provided enough concrete capability to transform "we believe this will work" into "see, we were right all along." The problem, as it always is in venture capital, lies in the gap between impressive demos and profitable businesses. A model that can write code or execute tasks is not the same as a model that makes money doing so at the scale these valuations demand. Yet this distinction was briefly obscured by the sheer enthusiasm—the kind of enthusiasm that only emerges when enough money has already been committed to require vindication.

What the current reckoning phase reveals is that capital may have massively outpaced actual commercial proof. Investors placed enormous bets on the assumption that AI would deliver on its promises at venture scale and speed—the same assumption that preceded the 2000 tech crash and the 2018 cryptocurrency collapse. The fact that AI actually works (which it does, to varying degrees) doesn't address the fundamental question: does it work *profitably* for the businesses that have raised billions in funding? The distinction between technological success and commercial success is one venture capital has repeatedly failed to maintain.

This three-year cycle suggests that venture capital's relationship to technology has become increasingly unmoored from reality. Investors can now move from suspicion to certainty in weeks based on demo footage, and from certainty to regret in months based on cash burn rates. The real story isn't whether AI works; it's whether anyone building it at venture scale was ever required to answer the question: why should this be worth this much money to investors right now? The Revenge of the AI bubble is simply the revenge of math against hope.

💀💀💀💀  Dumb Rating: 4/5 — Cyclically Delusional
Read full article →
Opinion

AI's Expensive Problem: It Costs Too Much to Do Too Little

After three years of 'this changes everything,' the market discovers that paying billions for AI doesn't actually replace workers.

M&A

Apotex Prices IPO at Top, Bets Market Loves Generics

A Canadian pharma company signals either commanding investor demand or a desperate closing window.

VC

Sequoia's Dual-Price Equity: One Valuation, Two Truths

Top-tier VC firm caught selling the same stock at different prices—a practice that would get founders banned from pitch meetings.

★ From the Glossary
"Autonomous agents"
AI systems that perform tasks without human intervention, often raised as evidence that AI has transcended marketing hype, at least until accounting questions arise.
VC

Sequoia's Dual-Price Equity: One Valuation, Two Truths

Top-tier VC firm caught selling the same stock at different prices—a practice that would get founders banned from pitch meetings.

💀💀💀💀 4/5 — Textbook Hypocrisy
Read more →
VC

SpaceX to Raise $75B, Because Aramco's Record Was Boring

The largest IPO ever will be underwritten by a company that has yet to prove it can consistently turn a profit on anything except government contracts.

Read more →
VC

Anthropic IPOs Into the Void as Customers Discover Buyer's Remorse

AI lab files to go public the moment Fortune 500s realize they're hemorrhaging millions monthly on technology that doesn't actually make money.

Read more →

M&A Morgue

More M&A Morgue →
M&A

Apotex Prices IPO at Top, Bets Market Loves Generics

A Canadian pharma company signals either commanding investor demand or a desperate closing window.

💀💀💀💀 4/5 — Peak Confidence Theater
Read more →
M&A

Nvidia Discovers PCs Exist, Panics Into New Market

The chip giant that cornered AI demand now desperately needs someone—anyone—to buy its processors for something other than training models.

Read more →
M&A

Grupo Mexico Finally Addresses 2014 Spill—Only 12 Years Late

When environmental liabilities become investor relations problems.

Read more →

PE Corner

More PE Corner →
Opinion

AI's Expensive Problem: It Costs Too Much to Do Too Little

After three years of 'this changes everything,' the market discovers that paying billions for AI doesn't actually replace workers.

💀💀💀💀 4/5 — Expensively Useless
Read more →
VC

Benchmark Discovers Growth Funds, Only 20 Years Late

The discipline-obsessed VC firm finally abandons its quaint $425M fund cap, proving even legends succumb to FOMO when everyone else is raising billions.

Read more →
Flop

Groq Pivots Away From Hardware It Never Sold

AI chip startup raises $650M to stop making chips, proving the entire thesis was always software theater.

Read more →

Unicorn Watch

More Unicorn Watch →
VC

AI Investors Complete Three-Year Cycle From Doubt to Ecstasy to Regret

The venture capital industry has now experienced an entire emotional arc without anyone proving AI actually makes money.

💀💀💀💀 4/5 — Cyclically Delusional
Read more →
Unicorn

SpaceX Alums Launch $200M SPAC to Monetize 'Frontier Economies'

When aerospace talent meets public market desperation, buzzwords become business plans.

Read more →
Unicorn

Google Admits It Has No Idea What AI Is Worth

Alphabet raises $80 billion because historical cash flow and actual revenue no longer matter when the future is imaginary.

Read more →
VC

Trump Discovers Socialism, Calls It a 'Beautiful Partnership'

The president pitches Uncle Sam as a limited partner in AI, proving even dealmakers eventually reinvent the wheel.

💀💀💀 3/5 — Accidentally Socialist
Read more →
Opinion

AI Industry Blames Beijing for Noticing Its Power Bills

When your business model faces legitimate scrutiny, the solution is apparently to claim foreign sabotage.

Read more →
Opinion

Google Drafts Water Guidelines While Communities Drown Its Permits

Nothing says 'we hear your concerns' like writing the rulebook you're about to break.

Read more →
D

About DumbCapital

DumbCapital covers venture capital and M&A in North America with the skepticism these markets have long deserved and rarely received. We are not impressed by large numbers. We are not moved by press releases. All articles are satirical commentary based on real, publicly reported deals. Nothing here is financial advice.

About Us  ·  Contact  ·  Privacy Policy